CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 36 filers reported holding CONSTELLATION PHARMCETICLS I in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $391,000 | +200.8% | 17,141 | +261.1% | 0.00% | – |
| Q4 2020 | $130,000 | +319.4% | 4,747 | +233.6% | 0.00% | – |
| Q3 2020 | $31,000 | -50.8% | 1,423 | -34.3% | 0.00% | – |
| Q2 2020 | $63,000 | +6200.0% | 2,165 | +11927.8% | 0.00% | – |
| Q1 2020 | $1,000 | -98.9% | 18 | -99.1% | 0.00% | – |
| Q4 2019 | $91,000 | +911.1% | 1,937 | +43.0% | 0.00% | – |
| Q3 2019 | $9,000 | -43.8% | 1,355 | +4.1% | 0.00% | – |
| Q2 2019 | $16,000 | -59.0% | 1,302 | -54.3% | 0.00% | – |
| Q1 2019 | $39,000 | +254.5% | 2,850 | -3.5% | 0.00% | – |
| Q4 2018 | $11,000 | -42.1% | 2,952 | +2.5% | 0.00% | – |
| Q3 2018 | $19,000 | – | 2,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
| Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
| VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
| Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
| Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
| VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
| Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
| Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |